Legal & General Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.1K | Hold |
|
|||||
|
2025
Q2 | $32.6K | Sell |
|
|||||
|
2025
Q1 | $266K | Buy |
|
|||||
|
2024
Q4 | $410K | Hold |
|
|||||
|
2024
Q3 | $560K | Buy |
|
|||||
|
2024
Q2 | $568K | Buy |
|
|||||
|
2024
Q1 | $734K | Buy |
|
|||||
|
2023
Q4 | $663K | Buy |
|
|||||
|
2023
Q3 | $519K | Sell |
|
|||||
|
2023
Q2 | $584K | Buy |
|
|||||
|
2023
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | $159K | Buy |
|
|||||
|
2022
Q3 | $131K | Sell |
|
|||||
|
2022
Q2 | $218K | Buy |
|
|||||
|
2022
Q1 | $339K | Hold |
|
|||||
|
2021
Q4 | $465K | Buy |
|
|||||
|
2021
Q3 | $457K | Buy |
|
|||||
|
2021
Q2 | $184K | Sell |
|
|||||
|
2021
Q1 | $247K | Sell |
|
|||||
|
2020
Q4 | $262K | Buy |
|
|||||
|
2020
Q3 | $229K | Sell |
|
|||||
|
2020
Q2 | $262K | Buy |
|